- recruitingPHASE3
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
This study is looking at a cream called ruxolitinib for children aged 6 to 11 with a skin condition called nonsegmental vitiligo. Researchers want to see how well it works to reduce white patches and if it's safe to use.
Argentina · Austria · Belgium - active not recruitingPHASE3
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)
This study is testing a new medicine called povorcitinib for people with a type of vitiligo called nonsegmental vitiligo. Researchers want to see if it's safe and helps improve the skin patches. It's a Phase 3 trial, meaning it's a later stage of research.
United States · Bulgaria · Canada